CDNA · NASDAQ · Medical - Diagnostics & Research

CareDx

Runs transplant testing, patient tools, and workflow support around organ health.

$49.72
After-hours close−0.06 (−0.12%)
At close$49.78(−4.93%)

Breakdown13F · Form 4

Institutions 106.12%Insiders 4.76%

A 13F quarter can total more than the shares outstanding — sub-advisers file the same block twice, and a filer's own share count can be a quarter stale. No split is drawn from it.

Shares outstanding 51.73M · Float 49.32M · 95.3% free float

Top shareholders13F · 13D/G · Form 4

HolderShares% outstandingFormFiled
BlackRock, Inc.4.81M9.31%13FAug 7, 2026
State Street Corp2.47M4.77%13FAug 7, 2026
Vanguard Capital Management LLC2.20M4.25%13FAug 13, 2026
Deerfield Management Company, L.P. (Series C)2.00M3.86%13FAug 14, 2026
Ark Investment Management LLC1.95M3.78%13FAug 14, 2026

Institutions13F, as of Jun 30, 2026

232 holders · 54.90M shares · 57 new positions · 133 increased · 68 reduced · 18 closed

HolderShares% outstandingChg q/qFiled
BlackRock, Inc.4.81M9.31%+292.6KAug 7, 2026
State Street Corp2.47M4.77%−291.5KAug 7, 2026
Vanguard Capital Management LLC2.20M4.25%+37.0KAug 13, 2026
Deerfield Management Company, L.P. (Series C)2.00M3.86%−193.4KAug 14, 2026
Ark Investment Management LLC1.95M3.78%−274.0KAug 14, 2026
Boston Partners1.94M3.75%+54.1KAug 4, 2026
Bamco Inc /NY/1.94M3.74%−1.40MAug 14, 2026
Gagnon Securities LLC1.77M3.42%+8.9KAug 5, 2026

Beneficial owners13D/G · 5% or more, as filed

Holder% of classSharesFormFiled
BlackRock, Inc.8.00%4.42M13GApr 17, 2025
State Street Corporation5.30%2.74M13GFeb 9, 2026
Bamco Inc /NY/5.11%2.72M13GNov 14, 2025

InsidersForm 4

InsiderRoleShares% outstandingFiled
John Walter JR Hannadirector, officer: President and CEO653.4K1.26%Jul 17, 2026
Abhishek Jainofficer: Chief Financial Officer319.7K0.62%Aug 5, 2025
Peter Maagdirector308.8K0.60%Jul 10, 2025
Keith Kennedyofficer: CFO & COO219.9K0.43%Jul 2, 2026
Jessica Mengofficer: Chief Commercial Officer168.3K0.33%Jul 2, 2026
Fred E. Cohendirector165.1K0.32%Jun 16, 2026
George Bickerstaffdirector134.1K0.26%Aug 6, 2026
Jeffrey Adam Novackofficer: Secretary and General Counsel106.1K0.21%Aug 6, 2026
Nathan Smithofficer: Chief Financial Officer75.0K0.14%Feb 4, 2026
Michael Goldbergdirector61.7K0.12%Aug 6, 2026

5 ten-percent owners hold 3.81M shares by Form 4, outside the officers-and-directors figure above · 20 people have not refiled in the last 18 months (1.86M shares), so they are not in the figure above

Latest trades

DateInsiderTypeSharesAvg priceOwned after
Aug 4, 2026
Michael Goldbergdirector
Sale44,700$47.0661,738
Aug 5, 2026
Jeffrey Adam Novackofficer: Secretary and General Counsel
Sale · 2 lots2,688$46.26106,075
Aug 4, 2026
Christine Cournoyerdirector
Sale16,000$46.9442,943
Aug 5, 2026
George Bickerstaffdirector
Sale20,000$46.29134,061
Jul 16, 2026
Hannah Valantinedirector
Sale · 2 lots28,779$36.1536,686
Jul 16, 2026
John Walter JR Hannadirector, officer: President and CEO
Sale · 2 lots118,000$37.79653,448
Jun 29, 2026
John Walter JR Hannadirector, officer: President and CEO
Sale39,900$29.24661,959
Jun 26, 2026
John Walter JR Hannadirector, officer: President and CEO
Sale100$29.00661,959
Jun 15, 2026
John Walter JR Hannadirector, officer: President and CEO
Sale17,683$24.03631,959
Jun 15, 2026
Hannah Valantinedirector
Sale12,103$23.1136,686

CongressHouse and Senate disclosures

Not reported.